These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11756667)

  • 1. Functional MRI detection of pharmacologically induced memory impairment.
    Sperling R; Greve D; Dale A; Killiany R; Holmes J; Rosas HD; Cocchiarella A; Firth P; Rosen B; Lake S; Lange N; Routledge C; Albert M
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):455-60. PubMed ID: 11756667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.
    Thiel CM; Henson RN; Dolan RJ
    Neuropsychopharmacology; 2002 Aug; 27(2):282-92. PubMed ID: 12093602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.
    Antonova E; Parslow D; Brammer M; Simmons A; Williams S; Dawson GR; Morris R
    J Psychopharmacol; 2011 Sep; 25(9):1256-65. PubMed ID: 20823079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.
    Paulus MP; Feinstein JS; Castillo G; Simmons AN; Stein MB
    Arch Gen Psychiatry; 2005 Mar; 62(3):282-8. PubMed ID: 15753241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
    Mintzer MZ; Griffiths RR
    Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.
    Gibbs RB; Burke AM; Johnson DA
    Horm Behav; 1998 Oct; 34(2):112-25. PubMed ID: 9799622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
    Schunck T; Mathis A; Erb G; Namer IJ; Demazières A; Luthringer R
    J Psychopharmacol; 2010 May; 24(5):701-8. PubMed ID: 19460871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of scopolamine on matching to sample paradigm and related tests in human subjects.
    Koller G; Satzger W; Adam M; Wagner M; Kathmann N; Soyka M; Engel R
    Neuropsychobiology; 2003; 48(2):87-94. PubMed ID: 14504417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic antagonist effects on executive control of attention.
    Thienel R; Kellermann T; Schall U; Voss B; Reske M; Halfter S; Sheldrick AJ; Radenbach K; Habel U; Shah NJ; Kircher T
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1307-17. PubMed ID: 19793402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation.
    Moosavi M; Khales GY; Abbasi L; Zarifkar A; Rastegar K
    Neuropharmacology; 2012 Apr; 62(5-6):2018-23. PubMed ID: 22248637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clorazepate, diazepam, lorazepam, and placebo on human memory.
    Healey M; Pickens R; Meisch R; McKenna T
    J Clin Psychiatry; 1983 Dec; 44(12):436-9. PubMed ID: 6140261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
    Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.
    Bahro M; Schreurs BG; Sunderland T; Molchan SE
    Psychopharmacology (Berl); 1995 Dec; 122(4):395-400. PubMed ID: 8657840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left prefrontal cortex control of novel occurrences during recollection: a psychopharmacological study using scopolamine and event-related fMRI.
    Bozzali M; MacPherson SE; Dolan RJ; Shallice T
    Neuroimage; 2006 Oct; 33(1):286-95. PubMed ID: 16919479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis.
    Lana D; Cerbai F; Di Russo J; Boscaro F; Giannetti A; Petkova-Kirova P; Pugliese AM; Giovannini MG
    Neurobiol Learn Mem; 2013 Nov; 106():246-57. PubMed ID: 24076274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.
    Diamond EL; Miller S; Dickerson BC; Atri A; DePeau K; Fenstermacher E; Pihlajamäki M; Celone K; Salisbury S; Gregas M; Rentz D; Sperling RA
    Neurology; 2007 Sep; 69(13):1331-41. PubMed ID: 17893294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.